Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Entrevista com Rogério Jorge, CEO da AES Brasil, com foco na geração de energia no Brasil.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Rogério Jorge. President of AES Brasil
Recent Videos
00:10:00
How LRT Capital's Lucas Krupinski Combines Economic Moats and Quant Discipline for Long-Term Outperformance|Mr. Tomicki,CEO,LRT Capital
00:10:00
AlphaBot Revolutionizes Alternative Investment Research with 10x Efficiency and Seamless Multi-Asset Integration at a Fraction of the Cost|Dmitri Alexeev,CIO,Man Group
00:10:00
Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG
00:10:00
Defying Convention with a Systematic Market Timing Strategy That Thrives in Volatility|Heeten H. Doshi,Founder,Doshi Capital
00:10:00
Exploiting market inefficiencies in undervalued and overlooked African markets|André Steyn,CEO,Steyn Capital
00:10:00
Europe’s Independent Hedge Fund Powerhouse with a Disciplined Edge and Global Reach|Dr Werner Goricki ,CIO,Prime Capital
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
Uncorrelated Returns, Predictable Yields: How Laureola’s Life Settlement Strategy Offers Stability and Alpha in Volatile Markets| Tony Bremness,CFA,Laureola Advisors
00:10:00
Why 2022 Marked the Greatest Asset Raising Environment in Hedge Fund History—and How Managers Can Win Big at Cap Intro Events|Don Steinbrugge,CEO,Agecroft Partners
00:10:00
John Katzman Urges EdTech Industry to Rethink Assumptions, Use Data for Support—Not Surveillance|John Katzman, Ceo, Noodle
00:10:00
Pioneering ESG-Driven Alpha Through Data, Discipline, and Sustainable Development Themes|Larry Abele ,CEO,Auriel Capital Management LLP
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
Blending Quantitative Precision and Trading Experience to Navigate Japan’s Markets with Systematic Edge|Aman Oberoi,CEO,K2Q Capital
00:10:00
Contrarian UK Equity Specialists Unlocking Asymmetric Value in a Post-Brexit Market|Alyx Wood,CIO,Kernow Asset Management
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures
00:10:00
Empowering Global Investment Managers with Infrastructure, Compliance, and Expertise|Clayton Heijman,CEO,Privium Fund Management
Suggestions
00:10:00
London Investment Opportunities Amidst European Union Affiliation|Tom Stafford,Cofounder And Managing Partner, DST Global
00:10:00
Exploring the Impact of Personal Choices on Financial Strategies: Insights and Reflections
00:10:00
Iron Ridge Resources: Advancing Gold and Lithium Projects Across Africa
00:10:00
DS Smith Purpose: Insights from CEO Miles Roberts | Miles W. Roberts - CEO of DS Smith
00:10:00
investment firm that focuses on cross-border financial and investment opportunities|Amb Clifford Sobel,Managing Partnerr,Valor Capital Group
00:10:00
Thierry Fautier is the VP of Video Strategy at Harmonic Inc.
00:10:00
We support leading companies across all sectors of financial services, including lending, credit & banking|Ben Savage,General Partner, Clocktower Technology Ventures
00:10:00
Empowering Change: A Leader's Perspective on Making a Positive Impact for Our Planet | Alan Brookes - Chief Executive Officer and Chairman of Arcadis
00:10:00
Mastering Investor Psychology with Fyooz Financial Planning | Dan Slagle, Founding Partner and Financial Planner of Fyooz Financial Planning
00:10:00
Market Update and I Bonds Considerations with Drew Tignanelli | Drew Tignanelli, Chairman, Financial Consulate Inc.
00:10:00
Ville Simola from Digimentalisti at Lassila & Tikanoja Oyj participates in the Nordic StrategyForum Executive IT 2017.
00:00:00
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals